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Abstract

Background: The manufacturer Ambu® recommends that the AuraOnce™ laryngeal mask be removed once the patient is
fully awake. Studies have shown benefit in removal of the laryngeal mask airway while a patient is deeply anaesthetized. Current
evidence is inconclusive, as to which approach is preferable and safer in adults.
Methods: one hundred and sixteen adult patients were randomly assigned to two groups of 58. For the deep arm; The AuraOnceTM laryngeal mask was removed after attaining an end tidal minimum alveolar concentration of Isoflurane of 1.15%.
Occurrence of airway complication(s) (One or more of the following; Airway obstruction requiring airway manipulation; Laryngospasm; Desaturation to 90% or less on pulse oximetry) was noted until the subject was fully awake (appropriate response
to command) in the post-anaesthesia care unit. For the awake arm; The AuraOnceTM laryngeal mask was removed on attaining
an end tidal minimum alveolar concentration of Isoflurane of <0.5% and an appropriate response to command or obtaining
appropriate response to command irrespective of end tidal concentration. Occurrence of airway complication(s) in theatre and
post anaesthesia care unit was recorded. Time to theatre exit was recorded for both groups.
Results: Baseline demographic characteristics were similar between the groups. More airway complications were encountered
in the Deep arm - 13 (22.4%) relative to the Awake arm -5 (8.6%), this was found to be statistically and clinically significant, P
value P=0.040, odds ratio 3.0622; 95% CI, 1.0139 to 9.2483.
Conclusion: The removal of the AuraOnceTM laryngeal mask while the patient is still deeply anaesthetised is not as safe as or
safer than awake removal.
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Introduction
The Laryngeal Mask Airway (LMA) is a supra-glottic airway device that was invented in 1981 by Archie Brain, an
Anaesthesiologist1. Its invention marked a turning point
in airway management in anaesthesia as it offered a convenient bridge between the use of an endotracheal tube
and facemask ventilation. Several advantages have been
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cited for its use as compared to the endotracheal tube
or the facemask, as an airway management option given
the appropriate indication. A meta-analysis by J. Brimacombe et al found that the LMA had thirteen advantages
over the endotracheal tube and four over the face mask as
techniques of airway management2.
Of the advantages, ease of use is a prominent feature
of the LMA. This relative ease of use and safety profile has led to the utilization of an estimated 200 million
LMAs globally as of 2013 3. At The Aga Khan University
Hospital, Nairobi (the site of this study), records availed
by the hospital showed that out of the 9138 general anaesthesia procedures carried out in the year 2015, 2032
(21.8%) were performed using the LMA. The utilization
of the LMA can be anticipated to increase given the cur-
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rent use of the device in procedures previously deemed
as contraindications. For instance, several publications report use in surgery performed in prone position; airway
surgery such as adeno-tonsillectomy and laparoscopy
The LMA can be considered to be a relatively new invention, as such, certain aspects of its use remain unsettled and research towards clarifying and improving these
aspects is ongoing. Whether to remove the LMA when
patient is “awake” (appropriate response to command) or
“deep” (anaesthetized) is one such area.
At our institution, the Ambu® AuraOnce™ laryngeal
mask, (ALM), is the design variant most utilized. The
Ambu® ALM features a special 70° curve that carefully replicates natural human anatomy. Moulded directly
into the tube for additional safety, the unique shape of
the mask makes correct insertion fast and easy without
putting extra stress on the upper jaw. The manufacturer of the ALM, Ambu®, recommends that the ALM be
removed once the patient is fully awake and protective
airway reflexes are active7. This recommendation was also
put forth by the inventor of the LMA, Archie Brain1
in 1983. There appears to be no objective evidence in
support of these recommendations, as such, use of the
LMA over the past 25 years has led to several studies to
substantiate this recommendation.
This gap in knowledge is summarized in the conclusion
of a Cochrane systematic review by Mathew P.J. et al,
that current evidence does not show superiority of either
approach8. They also noted that the quality of currently
available evidence was low.
An internet search also revealed several discussion forums/blogs on the same topic that yielded no conclusive
evidence cited or consensus from proponents of either
approach9,10.
The variation in individual practice is based primarily on
possible complications associated with either approach.
Deep removal being associated with possibility of airway
loss (soft tissue obstruction, laryngospasm) and subsequent desaturation and hypoxia. Whereas awake removal
being associated with the possibility of coughing, retching , agitation on emergence ,increased incidence of gastric content regurgitation , laryngospasm, biting hence
occluding LMA11. Why users opt for either technique is
not clearly delineated, as both approaches seem to have
several undesirable outcomes with unspecified frequency.
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This study set out to determine the proportion of airway
complications occurring in awake versus deep (anaesthetized) patients undergoing anaesthesia. The ultimate aim
was to distinctly quantify the proportion of airway complications associated with either approach thus aid decision
making on safe use of the ALM. Our research question
was: is there a difference in proportion in the occurrence
of airway complications between spontaneously breathing adults patients when the ALM is removed deep versus awake following Isoflurane general anaesthesia? We
hypothesized that there is no difference in the proportion
of airway complications in spontaneously breathing adult
patients when the ALM is removed deep or awake following isoflurane general anaesthesia. Our primary objective
was to compare the impact of having AuraOnce™ laryngeal mask removal deep versus awake on the occurrence
of airway complications following general anaesthesia in
spontaneously breathing adult patients. Our secondary
objectives were to compare the impact of deep versus
awake AuraOnce™ laryngeal mask removal on anaesthesia theatre turn- around time and the incidence of airway obstruction requiring airway manipulation; laryngospasm; desaturation to <90% on pulse oximetry among
patients where the AuraOnce™ laryngeal mask is removed deep and awake.
Methods
Approval to conduct the study was sought and obtained
from the Aga Khan University Research Ethics Committee prior to initiating the study. The study was carried out
between February 1 2017 and May 31 2017. Participant
flow diagram is shown in figure 1. It was a prospective
randomized control trial conducted at the Aga Khan
University Hospital, Nairobi. This is a 300 bed private
not-for-profit institution that provides tertiary and secondary level health care services. We included all ASA I
and II patients between 18 years- 65 years scheduled to
receive general anaesthesia with a laryngeal mask airway
(as the airway management device) for low to moderate
risk, elective surgery lasting less than two hours as per
protocol. Reasons for exclusion from the study were:
1.
Active/ongoing history of upper and or lower respiratory tract infection/disease
2.
Patients with a difficult AuraOnce™ laryngeal
mask insertion (defined as greater than two attempts)
3.
Patients with severe gastroesophageal reflux disease
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4.
5.
6.
7.
8.
9.
10.
hili
11.

Patients with a symptomatic hiatus hernia
Patients with a BMI> 40kg/m2
History of Obstructive sleep apnoea
Patients in whom muscle relaxants were to used
Patients with Mallampati class 3 and 4
Patients who did not give consent
Patients who did not understand English or Swa-

The following sample size calculation formulae were
used:

Patient with psychiatric disease

No study reviewed/found in literature was similar or
methodologically congruous with this study. Proportions
that may have been drawn from the aforementioned systematic review are mostly from paediatric studies. Given
the marked inherent anatomical and physiological differences of the adult airway vis-à-vis the paediatric airway
it was deemed imprudent to draw proportions of airway
complications from paediatric studies. The remaining
adult studies markedly differed in methodology and primary objective thus proportions from those studies were
ruled out as well. For instance the study by Nunez et al
(over and above our questions about the methodology
of this study) had a 3.03% incidence of airway complications in the awake arm versus 51.5% incidence in the
deep arm and the study by Gataure et al showed an incidence of 54% airway complications in the awake arm
versus 20% in the deep arm9,11
The difference in these proportions are 48.5% and 34%
respectively. The study by Gataure concedes that the incidence of complications in the awake arm were unusually
high and possibly caused by a methodological flaw. As for
Nunez’s study the remarkably high incidence of airway
complications is the deep arm was due to deliberate delay
in placing the Guedel airway, thus markedly exaggerating
complication incidence in that arm. Lastly the observational study by Hseih et al found no airway complication
in all their patients (this study only looked at removal of
the LMA while patients were deep)13.
Given evaluation of above data, the proportions drawn
from those studies to calculate the sample size would
have probably yielded a type II error, also bearing in mind
the small sample sizes utilized in these studies. The Aga
Khan University, Nairobi, Scientific committee therefore
advised that we consult the anaesthesia department faculty to advice on probable proportions based on their
clinical experience. A difference of 25% was thus settled
upon by consensus after reviewing the above studies and
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local practice.
We therefore resorted to expert opinion based on lack of
appropriate evidence in this field of study.

Where;
P0 = Probability of airway complications in the control
group (Awake arm = 0.25)
P1 = Probability of airway complications in the experimental group (Deep “anaesthetized” arm = 0.50)
m = Ratio of controls to experiment subjects (=1).
Z α = normal deviate corresponding to a type I error of
0.05 or 95% CI in a two tail test = 1.96
Z β = normal deviate corresponding to a Type II error of
20% equivalent to power 0.8 = 0.842
n = 116 (58 in each arm)
A sample size of 116 patients was drawn to demonstrate
a 25% difference in the occurrence of airway complications between patients in whom the ALM was removed
awake (appropriate response to command) versus in those
whom the ALM was removed deep (anaesthetized).
The study was powered to 80% with an alpha of 5%.
Patients were recruited from the day-care unit. Patients
were informed of the nature of the study, screened for
eligibility and recruited if eligible. Eligible patients had
verbal explanations on the purpose and nature of the
study. The patients who gave written informed consent
were enrolled into the study. Our statistician developed a
simple random allocation sequence using a computer algorithm. Each of the random numbers were sequentially
assigned to either; Awake arm: Green sticker; Deep arm:
Red sticker. The statistician serialized envelops to correspond to the random allocation sequence and insert the
green and red stickers in them. Patients who consented
for the study had the serialized envelop attached to their
file. The research assistant(s) opened the envelope and
African Health Sciences Vol 19 Issue 4, December, 2019

knew the group allocation and attached the sticker on the
patient data collection tool. Blinding to the interventions
was technically not possible for the study.
Once the patient was on the theatre table, ASA recommended14 monitoring set up (i.e. capnography, pulse
oximetry, temperature, electrocardiography and non-invasive blood pressure monitoring on Mindray Wato Ex65 monitor) applied and baseline vital signs measurement
taken. Intravenous access was obtained using a gauge 18
- 20 cannula. The patient was then pre-oxygenated at 6
litres oxygen flow rate for 3 minutes.
Induction was standardized as follows; Propofol 2 milligrams per kilogram IV (this was titrated to effect as is
our standard practice, to avoid inadvertent adverse effects such as hypotension and bradycardia given variable
patient response) and Isoflurane initiated at 2% on the
vaporizer; appropriate size ALM was inserted using the
classical technique, and inflated to a maximum volume according to size as per manufacturers recommendation7,15.
Placement confirmation was by auscultation and capnography and the ALM was then secured. Patients were manually ventilated until spontaneous breathing resumed (no
mechanical ventilation was carried out as it was thought
that this may confound outcome because resumption of
spontaneous breathing at the end of surgery may have be
delayed).
Opioid use portended to be a confounder on airway complications, as such, standardization was to be attained by
administering the opioid at beginning of surgery and at
recommended dosage i.e. Pethidine 1 milligrams per kilogram or Morphine 0.1mg/kg of Fentanyl 1 to 2 mcg/
kg. These doses were guided by the potential pain associated with the procedure range in which the ALM is used.
Routine use of traditional non-steroidal anti-inflammatory drugs as well as paracetamol was applied if there
were no contraindications. Opioids dosage was adjusted
as per patient requirements and deviation from the protocol noted. Suction if applied was documented in the data
collection tool. All patients in the deep arm were to be
suctioned on removal of the ALM.
The end of surgery was represented by the point marked
by end tidal of 1 MAC (1.15 for Isoflurane) as the anaesthetist dialled down Isoflurane anticipating end of procedure. At that point (end tidal of 1.15% Isoflurane) a timer
was started. The timer would be stopped once the patient
existed the theatre door.
African Health Sciences Vol 19 Issue 4, December, 2019

For the Deep arm of the study; Isoflurane vaporizer was
turned off; Oxygen dialled to 100% at 6 litres per minute
and on attaining an end tidal concentration of 1.15% Isoflurane, the ALM was removed (without deflating cuff)
and an appropriate sized oropharyngeal airway placed
and the patient positioned in “sniffing position”; a Hudson mask was then be placed at 6 litres oxygen flows. At
the discretion of the anaesthetist, the patient exited the
operating theatre in transit to the post anaesthesia care
unit (PACU).
For the awake arm of the study; Isoflurane would be
turned off; oxygen dialled to 100% at 6 litres flow rate;
on attaining an end tidal concentration <0.5% Isoflurane
and an appropriate response to command (as defined) the
ALM was removed, however, if the patient was noted to
be waking up prior to attaining an end tidal of < 0.5%
and had an appropriate response to command then the
ALM was withdrawn irrespective of end tidal concentration of Isoflurane a Hudson mask would then be placed
and oxygen administered at flows 6 litres flow rate. At the
discretion of the anaesthetist the patient exited the operating theatre in transit to the PACU.
Intra-operative and post-operative data was collected by
trained research assistants and PACU nurses using a data
collection form. This continued until the patient was fully
awake and responding appropriately to command (as defined) for both groups from end of surgery (as defined).
Parameters of interest were: Airway obstruction (defined
as need for airway manipulation); laryngospasm; desaturation to 90% or less on pulse oximetry. The composite
all the parameters was defined as airway complication(s).
All the raw data in this study was filed in suitable box file
and flash disk which were kept locked in the principal investigator’s locker. All data sheets<="" span="" style="font-family: "Times New Roman";">were checked for
completeness prior to filing.
Categorical variables were summarized using frequency
and percentages while continuous variables were summarized using descriptive statistics i.e. means. Pearson Chi
Square test was carried out to test the difference in proportions between the incidence of airway complications
in the deep arm and awake arm following ALM removal. The secondary outcomes yielded continuous data i.e.
time it takes to exit theatre. The Mann Whitney test was
used for the means of the time to exit theatre for deep
and awake ALM removal as the data was non parametric
in distribution. All data analysis was done at 95% level of
significance using STATA version 15.
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Results
A total of 135 subjects were recruited, 19 were excluded
and 116 proceeded into the later part of the study, 58
subjects randomized in each arm. No drop outs during
collection or analysis were encountered. There was no re-

markable difference between the participants in the two
arms of the study as shown in table 1.There were 5 out
of 58 patients in the awake arm who developed airway
complications (as per definition) and 13 out of 58 patients in the deep arm who developed airway complications (as per definition) as shown in table 2.

Table 1. Baseline characteristics of patients between awake and deep arm
Arm
Awake (n=58)

Deep
(n=58)

18 – 27
28 – 37
38 – 47
48 – 57
58 – 67

8
18
16
14
2

13
23
12
8
2

Male
Female
Specialty
Gynaecology
General Surgery
Orthopaedics
Urology

19
39

15
43

2
46
9
1

11
36
9
2

Age

Sex

Duration of surgery (mins)
<=30
9
11
31 – 60
36
24
61 - 90
11
15
91 - 120
2
6
121 - 150
0
0
151 - 180
0
1
181 - 210
0
1
Mean duration
51.29 (±19.432)
60.31 (±33.307)
Opioid use
Fentanyl
31
27
Tramadol
2
1
Morphine
14
10
Pethidine
24
29
Remifentanyl
0
1
Notes:
 Pearson Chi Square test was applied
◊ Yates' correction p-value
 Mann Whitney U-test was applied
P values of less than 0.05 was considered statistically significant.
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p-value

0.405

0.415

0.051

0.74 ◊

0.61 

0.94 ◊
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Table 2: Comparison of occurrence of airway complication between awake arm and deep arm

Study arms

Awake
Deep

Total

Airway Complication (as per definition)
Yes
No
n (%)
n (%)
5(8.6)
53(91.4)
13(22.4)
45(77.6)
18
98
χ2 (1) = 4.209, P value 0.040

Total

58
58
116

Notes:
 Pearson Chi Square test was applied
P values of less than 0.05 was considered statistically significant.
The mean theatre exit time (as measured from the time
1 MAC of isoflurane was noted at the end of surgery)
for the awake arm of the study was 12.29 minutes (±
3.637) and for the deep arm of the study was 7.72 minutes (± 5.730) as shown in table 3. There were 5(8.6%)
patients out of 58 in the awake arm who developed airway obstruction requiring airway manipulation compared
to 13(22.4%) patients out of 58 in the deep arm who developed airway obstruction requiring airway manipulation
as shown in table 4.

None of the patients in the awake arm developed laryngospasm, compared to 2 (3.4%) patients out of 58 who
developed laryngospasm in the deep arm as shown in table 5. None of the patients in the awake arm were noted
to have desaturated to less than <90% on pulse oximetry
after the ALM was removed, compared to 2 (3.4%) patients out of 58 in the deep arm who did developed desaturation to <90% on pulse oximetry as shown in table
6.

Table 3: Comparison of mean duration of theatre exit time between awake arm and deep arm
Study arms

Mean theatre exit time in minutes
Awake
Deep
12.29(± 3.637)
7.72(± 5.730)

P value
0.0001 

Notes:
 Mann Whitney U-test was applied ( z score = 6.424452, z critical {5% two tailed} =1.959964, p value <
0.0001)
P values of less than 0.05 was considered statistically significant.
Table 4: Comparison of occurrence of airway obstruction requiring airway manipulation
between awake arm and deep arm

Study arms

Awake
Deep

Total

Obstruction
Yes
n (%)

No
n (%)

5(8.6)
13(22.4)

53(91.4)
45(77.6)

Total

18
98
χ2 (1) = 4.209, P value 0.040

58
58
116

Notes:
 Pearson Chi Square test was applied
P values of less than 0.05 was considered statistically significant.
African Health Sciences Vol 19 Issue 4, December, 2019
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Table 5: Comparison of occurrence of laryngospasm between awake arm and deep arm

Study arms

Laryngospasm
Yes
n (%)
0(0)
2(3.4)

Awake
Deep

Total

Total
No
n (%)
58(100)
56(96.6)

2
114
χ2(1) = 2.035, P value 0.154

58
58
116

Notes:
 Pearson Chi Square test was applied
P values of less than 0.05 was considered statistically significant.
Table 6: Comparison of occurrence of desaturation to <90% on pulse oximetry between
awake arm and deep arm

Study arms

Desaturation
Yes
n (%)
0(0)
2(3.4)

Awake
Deep

Total

Total
No
n (%)
58(100)
56(96.6)

2
114
χ2(1) = 2.035, P value 0.154

58
58
116

Notes:
 Pearson Chi Square test was applied
P values of less
than
0.05 was considered
statistically significant.
Figure
1: CONSORT
Flow Diagram

Enrollment

Assessed for eligibility (n=135)

Excluded (n= 19)
♦ Not meeting inclusion criteria (n= 19 )
♦ Declined to participate (n= 0 )
♦ Other reasons (n=0 )

Randomized (n=116)

Allocation

Allocated to intervention deep LMA removal
(n=58)
♦ Received allocated intervention (n=58 )
♦

Allocated to control awake LMA removal (n=
58)
♦ Received allocated intervention (n=58 )

Did not receive allocated intervention (give
reasons) (n=0 )

♦

Did not receive allocated intervention (give
reasons) (n= 0 )

Follow-Up
Lost to follow-up (give reasons) (n= 0)

Lost to follow-up (give reasons) (n=0)

Discontinued intervention (give reasons) (n= 0)

Discontinued intervention (give reasons) (n=0)

Analysis
Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

Analysed (n=58)
♦ Excluded from analysis (give reasons) (n=0)

Figure 1: CONSORT Flow Diagram

Enrollment
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Assessed for eligibility (n=135)

Excluded (n= 19)
♦ Not meeting inclusion criteria (n= 19 )
♦ Declined to participate (n= 0 )
♦ Other reasons (n=0 )
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Discussion
The key finding of this study was that there was a statistically significant difference in the occurrence of airway
complication (defined as - One or more of the following;
airway obstruction requiring airway manipulation; laryngospasm; desaturation to 90% or less on pulse oximetry)
between the awake (defined as ‘MAC awake’ - Alveolar
concentration at which 50% concentration} for the commonly used volatile agents) arm and deep (at-least 1 MAC
-Minimum alveolar concentration of Isoflurane) arm.
As regards airway obstruction requiring airway manipulation fewer patients in the awake arm developed airway
obstruction requiring airway manipulation compared to
those in the deep arm. This was found to be statistically
significant p = 0.040. As regards laryngospasms, none of
the patients in the awake arm developed laryngospasm,
compared to 2/58(3.4%) patients who developed laryngospasm in the deep arm. This was found not to be statistically significant (p = 0.154). There was a similar conclusion with the latter as regards desaturation to <90%
on pulse oximetry as the proportions were identical and
thus p = 0.154.
This study found that there was a statistically significant
difference (p < 0.0001) in the mean theatre exit time between the awake arm, 12.29 minutes (± 3.637) and the
deep arm, 7.72 minutes (± 5.730).
The primary outcome results of this study thus reject the
null hypothesis that there is no difference in the proportions of airway complications in spontaneously breathing
adult patients when the laryngeal mask airway is removed
deep or awake following isoflurane general anaesthesia.
There was a significant difference in complications, with
the deep arm show more adverse outcome.
The main finding of the study contrasts with the conclusion in the systematic review by Mathews and colleagues,8 that there is no superiority in either approach.
The awake approached showed significantly less adverse
outcomes statistically. Clinically, this study set out to have
a 25% difference between the two arms be considered
as clinically significant. The difference between the two
arms was 13.8%, which did not surpass our set threshold.
Despite this, the airway complications studied are critical
events that portend adverse sequelea if unchecked. As
such, it would be imprudent to disregard this finding as
clinically insignificant, also considering that the calculated
odds ratio was 3.0622; 95% CI, 1.0139 to 9.2483.
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The study by Gataure et al11 had a contrary conclusion
to this study i.e. deep (anaesthetized) LMA removal was
associated with less airway complications compared to
awake LMA removal. Gataure et al found a complication
incidence of 20% in the deep arm and 54% in the awake
arm (Total of 66 patients). The authors (Gataure et al)
contend that the markedly high proportion of complications in the awake group may have been due to lack
of familiarity of PACU nurses with the LMA who subsequently ended up removing the LMA before patient
was actually truly awake. This is in contrast to this study,
where the awake arm had complication incidence of
8.6%. This marked reduction in incidence may be due
to the fact that the ALM in this study was removed in
theatre by an anaesthetist (rather than PACU by a nurse).
Also the seemingly more objective and standard point of
assessing wakefulness i.e. on attaining an end tidal concentration <0.5% Isoflurane and an appropriate response
to command (as defined) may have aided in achieving
the remarkably lower incidence of complications in the
awake arm of this study relative to Gataure et al’s study.
As regards complications in the deep arm, Gataure et al
study looked at coughing, biting, retching, vomiting, excess saliva, Airway obstruction. The only comparable parameter with this study was airway obstruction of which
Gataure’s study had zero occurrence, this differs from
our incidence of 22.4%. This is possibly because the patients in Gataure’s study were recovered in the lateral position compared to this study in which participants were
recovered in the supine position.
In contrast to the only other adult study that specifically
sought a difference in airway complications during deep
versus awake LMA removal by Nunez et al12, this study
had a far lower complication rate in the deep arm (17.2%
relative to 51.5% in Nunez’s study). This may have been
due to a difference in methodology, whereby in this study
a Guedel airway was placed immediately after removing
the ALM in the deep arm as compared to the Nunez
study protocol, where the Guedel airway was put only if/
when airway obstruction occurred. In the author’s opinion Nunez’s protocol was counterintuitive, as the effects
of volatile agents on muscle tone (i.e. reduction in tone)
would predispose the patient to airway obstruction. This
may explain the higher complication rate in the deep arm
of Nunez’s study. The awake arm of Nunez’s study is by
and large comparable to this study’s results (8.6% relative
to 6.1% in Nunez’s study). This similarity in incidence
2961

may lend credence to the use of a single, objective end
point to define appropriate response to command, as illustrated in Nunez’s study as well as this study. Both these
studies utilized opening mouth to command as a marker
of wakefulness/appropriate response to command.
As compared to the study by Heidari et al16 this study
showed that depth of anaesthesia may possibly affect
the occurrence of airway complications contrary to what
Heidari et al found.
Baird et al study had remarkably high occurrence of airway complications in both arms17, this may be inferred to
be due to lack of clear specified end points, also no exclusions may have led to recruitment of patients who were
already at risk of upper airway obstruction. The results
of Baird et al’s study relative to this on show that patient
selection is critical irrespective of whether the LMA is
removed deep or awake.
As per the literature review it is worth noting that this
is the only study to our knowledge where Isoflurane has
been used as the sole volatile anaesthetic agent to examine the impact of deep versus awake ALM removal on
airway complications. Also, the clear definition of the objective end points used to define ‘deep’ and ‘awake’ makes
the study reproducible in contrast to the aforementioned
studies and possibly resulted in the significantly less occurrence of airway complications in both the awake arm
and the deep arm of the study. Therefore, this study adds
unique knowledge with regards to the use of laryngeal
mask airway as a supra-glottic airway device during general anaesthesia.
Limitations
This study was relatively small and this may affect the
generalizability of the results obtained from this study.
The method of randomisation chosen was progressively
less random as the number of envelopes reduced, this affected the quality of the recruitment. We did not use objective monitoring like Bispectral Index Monitoring (BIS)
or Entropy in our deep or awake arm since they were not
readily available.
Conclusion
On the basis of the results of this study, it can be concluded that there is a difference in the proportions of
airway complications in spontaneously breathing adult
patients when the laryngeal mask airway is removed deep
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or awake following Isoflurane general anaesthesia. Therefore, the removal of the ALM while the patient is deep
(anaesthetized) is not as safe as or safer than awake removal of the ALM as recommended by the manufacturer, Ambu®, and also recommended by Archie Brain in
the Intavent laryngeal mask airway manual. Therefore, in
cases where it is desirable to remove the laryngeal mask
airway while the patient is deep, extra vigilance is required
in view of the increased potential for adverse airway complications.
Registration PACTR201705002284531.
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